BRD4-S Drives Colorectal Cancer Progression via DDX27-Regulated Splicing and MAPK Signaling Activation
Frontiers in Bioscience-Landmark · 30.10.2025 · 30 (10)
DOI: 10.31083/fbl46158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 30.10.2025. Verfasst von Chenlu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Second Affiliated Hospital of Nantong University and Nantong First People's Hospital, 226001 Nantong, Jiangsu,…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Transcription Factors, DEAD-box RNA Helicases, Cell Cycle Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wu Jieping Medical Foundation Clinical Research Special Grant Program.
Abstract (Originalsprache)
Background
As a major contributor to cancer-associated deaths, advanced colorectal cancer (CRC) has a constrained range of effective treatment options. The short isoform of bromodomain-containing protein 4 (BRD4-S) has recently been implicated as a potential oncogenic driver; however, its regulatory mechanisms and functional role in CRC remain incompletely understood.
Methods
BRD4-S expression, regulation, and function in CRC were investigated through bioinformatics analyses of the Cancer Genome Atlas (TCGA) datasets, in vitro studies using CRC cell lines (HT29, SW620), and in vivo xenograft models in nude mice. Experimental approaches included quantitative real-time PCR (qRT-PCR), Western blotting, co-immunoprecipitation, RNA immunoprecipitation, immunofluorescence, colony formation, Cell Counting Kit-8 (CCK-8), and scratch assays. Gene enrichment and interaction analyses were performed to identify relevant pathways and molecular partners.
Results
BRD4-S was markedly upregulated in CRC tissues and cell lines, and elevated BRD4-S expression correlated with poorer patient survival. Silencing BRD4-S, but not BRD4-L, significantly impaired CRC cell proliferation, migration, and tumor growth in vivo. Mechanistically, the RNA helicase DEAD-box helicase 27 (DDX27) interacted with Serine and Arginine Rich Splicing Factor 6 (SRSF6) to promote alternative splicing of BRD4 pre-mRNA toward the BRD4-S isoform. Inhibition of SRSF6 phosphorylation suppressed BRD4-S production and blocked activation of the mitogen-activated protein kinase (MAPK)/extracellular regulated protein kinases ERK signaling pathway, identified as a key downstream effector of BRD4-S.
Conclusions
This study defines a novel DDX27–SRSF6–BRD4-S–MAPK/ERK signaling axis that drives CRC progression. These findings underscore the therapeutic potential of targeting BRD4 isoform switching and its regulatory splicing machinery in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Second Affiliated Hospital of Nantong University and Nantong First People's Hospital, 226001 Nantong, Jiangsu, China.
- Department of Clinical Laboratory, The Affiliated Hospital of Nanjing University of Chinese Medicine and Nantong Traditional Chinese Medicine Hospital, 226001 Nantong, Jiangsu, China.
Förderung
- Wu Jieping Medical Foundation Clinical Research Special Grant Program
Zitieren
APA
Wang, C., Hong, H., Zhou, L., Chu, F., & Chen, X. (2025). BRD4-S Drives Colorectal Cancer Progression via DDX27-Regulated Splicing and MAPK Signaling Activation. Frontiers in Bioscience-Landmark, 30(10). https://doi.org/10.31083/fbl46158
Vancouver
Wang C, Hong H, Zhou L, Chu F, Chen X. BRD4-S Drives Colorectal Cancer Progression via DDX27-Regulated Splicing and MAPK Signaling Activation. Frontiers in Bioscience-Landmark. 2025;30(10). doi:10.31083/fbl46158
BibTeX
@article{Wang2025,
author = {Wang, Chenlu and Hong, Hong and Zhou, Lining and Chu, Fuying and Chen, Xiang},
title = {BRD4-S Drives Colorectal Cancer Progression via DDX27-Regulated Splicing and MAPK Signaling Activation},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
volume = {30},
number = {10},
doi = {10.31083/fbl46158}
}
EUVIMED